Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
Move to accelerate cancer care expansion across India
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Among his notable contributions is the development of the NAGI Stent, a widely adopted device for the drainage of pancreatic pseudocysts
This combination works to break down rough patches, improve moisture retention, and enhance overall skin texture
Subscribe To Our Newsletter & Stay Updated